Dr. Joshua Grill publishes an essay an article in the Philadelphia Inquirer with colleague Jason Karlawish, MD, of the University of Pennsylvania about blood tests for Alzheimer’s disease. Click here to read more.
Dr. Joshua Grill comments on colleagues latest essay on advances in diagnosis and therapeutics. Click here to read more.
UCI MIND Director, Dr. Joshua Grill shares updates and highlights from the Alzheimer’s Association International Conference (AAIC) that occurred this past July.
Staff Research Associate, Deanna Dang, comments on outreach for the ACAD study. Click here to read more.
UCI MIND Director, Joshua Grill, PhD, discusses the strengths and limitations of a recently published article from Washington University on disclosure of biomarker results. To read the AlzForum summary and comments including Dr. Grill’s, click here.
Staff Research Associate, Kenny Li, MS, comments on the CARE registry. Click to read more
The evening featured a pre-concert panel that included the composer, the conductor of the UC Irvine Chamber Singers & Concert Choir, Dr. Joshua Grill, and two research participants who represented the lived experience of individuals living with cognitive impairment. Click here to read more.
Results from Dr. Joshua Grill’s Nicotinamide as an Early Alzheimer’s Disease Treatment (NEAT), a phase 2 clinical trial of nicotinamide in early Alzheimer’s, were recently published in Neurology and highlighted in PsyPost, an online psychology news outlet. To read the article published in PsyPost, click here.
UCI MIND Director, Dr. Joshua Grill, comments on advances in Alzheimer’s research. Click to read more
UCI MIND Director, Dr. Joshua Grill, comments on the recent NYT article. Click to read more
Dr. Joshua Grill and colleague from Penn publish essay on clinical implications of new drugs. Click to read more
This Hispanic Heritage Month, we proudly recognize the invaluable contributions of our faculty, staff, community partners, and supporters who are dedicated to addressing Alzheimer’s disease and related dementias in the Hispanic and Latino communities. Click to read more
Grill lab member and a PhD candidate, Marina Ritchie received the Carl W. Cotman Scholar Awards at 15th annual Emerging Scientists Symposium led by the Research and Education in Memory Impairments and Neurological Disorders (REMIND) on Wednesday, March 13, 2024.
UCI MIND Director, Dr. Joshua Grill was recently interviewed by the OC Register about the Institute’s role in being a reliable source of information about Alzheimer’s disease.
“Music can really affect the brain in ways that are medicinal” says Dr. Joshua Grill of UCI MIND, in an interview with CNN.
Chief of the Memory Disorders Division at UCI, Dr. S. Ahmad Sajjadi, who co-authored a blog post with UCI MIND director, Dr. Joshua Grill was interviewed by the JAMA Network to discuss further about AD-Detect
UCI MIND Director, Dr. Joshua Grill is one of the three principal investigators for the National Institute on Aging grant that will fund CARE 2.0.
UCI MIND Director, Dr. Joshua Grill is quoted in Nature about the importance of diverse populations in drug trials.
UCI MIND Director, Dr. Joshua Grill, is named one of this year’s OC50 (50 people shaping the future of healthcare in Orange County) in the Orange County Business Journal.
A training course, directed by UCI MIND Director, Dr. Joshua Grill and Director of Biostatistics at USC Alzheimer’s Therapeutic Research Institute.
UCI MIND Director, Dr. Joshua Grill is quoted in a National Geographic article about lecanemab
UCI MIND Director, Dr, Joshua Grill is quoted in the Washington Post about the meaningfulness of lecanemab’s clinical benefit. Further discussion on this topic is accessible on UCI MIND blog post.
“Alzheimer’s is the most important medical condition society faces and we need an army of citizen volunteers to participate in drug trials,” said UCI MIND’s Joshua Grill, with study leader Marina Ritchie. UCI MIND
Epidemiologist Dr. Christian Salazar of UC Irvine discusses how Alzheimer’s disproportionately affects the Latino community on Yahoo News and CBSLA.
Christian Salazar, PhD, MPH, Associate Project Scientist at UCI MIND discusses his epidemiological research in Latino communities to engage, educate, and encourage increased representation of Latinos in clinical trials.
In this episode of UCI MINDcast, meet Hye-Won Shin, PhD, Director of Asian American Community Outreach.
Truth or Myth? “All people with dementia have Alzheimer’s”. Director of UCI MIND, Dr. Joshua Grill provides explanation and insight.
Director of UCI MIND, Dr. Joshua Grill joins a live discussion and Q&A on the status of new treatments for Alzheimer’s disease in 2021.
Director of Asian American Community Outreach at UCI MIND and Executive Director of Somang Society, Dr. Hye-Won Shin, discusses Alzheimer’s disease and dementia.
Director of UCI MIND, Dr. Joshua Grill joins a live discussion and Q&A on the status of new treatments for Alzheimer’s disease in 2021.
Truth or Myth? “Only those diagnosed with Alzheimer’s disease can participate in clinical trials.” UCI MIND Associate Project Scientist and an epidemiologist, Christian Salazar, PhD provides explanation and insight.
OC World produced documentary “Hope Dies Last”, features UCI MIND faculty members, Drs. Joshua Grill and Leslie Thompson.
